While there is considerable evidence supporting that myeloid Arg1 deficiency during amyloidosis exacerbates AD-typical neuropathology and behavioral impairments, the underlying mechanisms have yet to be fully clarified. This evidence concerns the gene ARG1 and Alzheimer disease.